Clinical Trial Update: Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy [Phase 1, Phase 2]

View source ↗

Summary

An update on a safety-focused clinical trial evaluating high-dose ranibizumab for polypoidal choroidal vasculopathy (Phase 1/2). The current trial status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: Retina Consultants of Hawaii | Conditions: Polypoidal Choroidal Vasculopathy | Phase 1, Phase 2 | Status: UNKNOWN